Pediatric nephrology collection highlights recent pediatric kidney research and reviews covering topics such as AKI, vasculitis prognosis, infant hypertension, transplantation, palliative care, cancer-related ESKD risk, and treatments for nephrotic syndrome. https://twp.ai/9OXgfo
New #ASNJASN study published simultaneously with #ATC2026Boston looked at patients referred for kidney transplantation in 2014-2025 & found barriers to transplant access. Only 48% of referred patients progressed to evaluation, 19% reached waitlisting, & 10% received a kidney https://twp.ai/9OXg9U
When it comes to the prevention of recurrent kidney stones, many clinicians are left wondering: what works? Read a recap of a recent study in #ASNKidneyNews: https://twp.ai/9OXRse
New Podcast: In this #ASNCJASN podcast, Drs. Roumie and Hung summarize the main findings from their study on "Target Emulation Trial: GLP1RA, SGLT2i, DPP4i for Kidney Outcome Prevention" on behalf of their colleagues. Tune in here: https://twp.ai/9OWqtU
Potassium: target or surrogate of optimized care in heart failure? Perspective in #ASNJASN argues that the POTCAST trial may reflect MRA intensification more than potassium targeting. https://twp.ai/9OXm6d
Is gene therapy a promising path forward for cystinosis? Read a review of the early evidence in #ASNKidneyNews: https://twp.ai/9OXRn2
Research letter in #ASNJASN highlights the need for a comprehensive evaluation of acid-base status in CKD, advocating for integrating blood pH and PCO2 data, along with venous-to-arterial conversion formulas for enhanced clinical phenotyping. https://twp.ai/9OXm43 Daniel Batlle, MD
New Podcast: Drs. Benjamin Catanese and Daniel Edmonston discuss their study, “Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure,” with #ASNJASN Editor Manjula Kurella Tamura. Listen here: https://twp.ai/9OWqv4
Study finds that most dialysis patients haven’t formally documented their care wishes. Improving understanding and creating structured opportunities to discuss goals of care can empower patients and ensure care aligns with their preferences. #ASNKidney360 https://twp.ai/9OXJrf
After a bracket of votes and a flurry of social media debates, #NephMadness 2026 concluded with B-Cell Modulators defeating C3G Treatment for the win, reflecting the growing impact of B-Cell Modulators. Read a recap in #ASNKidneyNews: https://twp.ai/9OXRsK
